HIGHLIGHTS
- who: Didar Yanardag Acik from the (UNIVERSITY) have published the Article: Can ELABELA be a novel target in the treatment of chronic lymphocytic leukaemia?, in the Journal: (JOURNAL)
- what: The authors aimed to draw attention to a new molecule worthy of research in targeted treatment. The authors aimed to investigate the relationship between ELA and CLL because the apelinergic system blocks the caspase system that induces apoptosis and validate the anti-apoptotoic effects of ELA that have been demonstrated in previous studies. The authors showed that serum ELA levels were significantly high in patients with . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.